ESR1 and benign neoplasm: In general, ESR1 gene expression has a similar pattern to ERα immunoexpression, with a loss of gene and receptor expression in high-grade carcinomas [20,21], and lower protein scores in more aggressive carcinomas compared with benign tumors and normal mammary glands [46].